Retinoid class drugs

14 results

  • Absorica

    (isotretinoin)
    Sun Pharmaceutical Industries, Inc.
    Usage: ABSORICA and ABSORICA LD are indicated for treating severe recalcitrant nodular acne in non-pregnant patients aged 12 and older, unresponsive to conventional therapies. A two-month waiting period is recommended before a second course, as acne may continue to improve after initial treatment.

  • Accutane

    (ISOTRETINOIN)
    JG Pharma Inc.
    Usage: Accutane is indicated for severe recalcitrant nodular acne in patients unresponsive to conventional therapy, including systemic antibiotics. It is contraindicated in pregnant patients due to potential life-threatening birth defects. A single 15 to 20-week treatment course may lead to prolonged remission.

  • Aklief

    (trifarotene)
    Galderma Laboratories, L.P.
    Usage: AKLIEF Cream is a retinoid indicated for the topical treatment of acne vulgaris in patients aged 9 years and older.

  • Altreno

    (tretinoin)
    Bausch Health US, LLC
    Usage: ALTRENO® (tretinoin) lotion, 0.05% is indicated for the topical treatment of acne vulgaris in patients aged 9 years and older.

  • Arazlo

    (tazarotene)
    Bausch Health US, LLC
    Usage: ARAZLO® (tazarotene) lotion, 0.045% is indicated for the topical treatment of acne vulgaris in patients aged 9 and older.

  • Duobrii

    (halobetasol propionate and tazarotene)
    Bausch Health US, LLC
    Usage: DUOBRII® (halobetasol propionate and tazarotene) Lotion is indicated for the topical treatment of plaque psoriasis in adults.

  • Epiduo

    (adapalene and benzoyl peroxide)
    Galderma Laboratories, L.P.
    Usage: EPIDUO gel is indicated for the topical treatment of acne vulgaris in patients aged 9 years and older.

  • Fabior

    (tazarotene)
    Mayne Pharma
    Usage: FABIOR® (tazarotene) Foam, 0.1% is indicated for the topical treatment of acne vulgaris in patients aged 12 years and older.

  • Retin-a micro

    (Tretinoin)
    Bausch Health US LLC
    Usage: Retin-A Micro® is a retinoid indicated for topical use in the treatment of acne vulgaris.

  • Sohonos

    (palovarotene)
    Ipsen Biopharmaceuticals, Inc.
    Usage: SOHONOS is indicated for reducing the volume of new heterotopic ossification in adults and pediatric patients with fibrodysplasia ossificans progressiva (FOP), specifically in females aged 8 years and older and males aged 10 years and older.